& Wolf, C
While insurers often cover GLP-1 drugs when prescribed for diabetes or heart conditions, more than half of employer insurance plans refused to cover the medications for obesity
GLP-1 receptor agonists, the drug class behind Ozempic, Wegovy, and Mounjaro, have moved from a pharmaceutical story to a commercial one, and the CPS executives who have not yet treated them as a business problem are running out of time to get ahead of them
Every bite carries more weight
Vitamin B5 (Pantothenate) effectively synthesizes the enzymes that form an integral part of various metabolic pathways such as carbohydrates, lipids, and proteins
Even worse, GLP-1 can signal the brain areas that control nausea, exacerbating symptoms if youre already stressed or anxious